Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current CEO ...

Company also reports positive data from trial of combination treatment for a form of prostate cancer Pfizer Inc.'s stock dipped 2.5% Thursday after two of its former executives said they would not ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

The overall survival data from the late-stage trial will help Pfizer in its bid to expand the label for Talzenna and Xtandi, ...

Starboard said a former CEO and CFO had assisted in its activist campaign but then were pressured to express support for the ...

"We have decided not to be involved in the efforts of Starboard Value regarding Pfizer. We are fully supportive of Pfizer ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist ...

Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...

Former Chief Executive Ian Read and ex-Chief Financial Officer Frank D'Amelio said they decided not to be involved in Starboard Value's campaign, and expressed support for current Chairman and CEO ...

Starboard Value LP (together with its affiliates, "Starboard" or "we"), a significant shareholder of Pfizer Inc. (NYSE: PFE) ("Pfizer" or the "Company"), today issued the below letter to Company's ...

Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, ...